text.skipToContent text.skipToNavigation
Need help? Please contact us
Pharma & Biotech

Cord Blood CD34+ ≥2 million cells

Catalog #: 2C-101X

Cryopreserved ampule of Human Cord Blood CD34+ stem/progenitors containing ≥2 million cells. Individual vials have 1 million cells each. Two or more vials are available per batch. Entire batch needs to be purchased. The price is per vial. 


This product is also available with HLA information if your research requires it:
≥1 million cells 
≥ 2 million cells 


Product Overview

Lonza cord blood CD34+ cells (2C-101X) contain hematopoietic stem and progenitor cells, are isolated from cord blood mononuclear cells (MNCs) via positive immunomagnetic separation. They are ideal for studies relating to transplantation and stem cells and humanized mouse model development. The number of cells typically obtained from cord blood can be limiting and pose a challenge. Cord blood derived CD34+ (2C-101X) consists of ≥2 million cells hematopoietic stem cells from the same donor. Cells are ethically sourced and are isolated using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. Large inventory supports stable supply from a single vendor.


Lonza guarantees the performance of Cells only if appropriate Lonza recommended Media and Reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees. If you need assistance in selecting the appropriate media, reagents, or protocol, please contact Lonza Scientific Support.


More cells: Increase productivity with larger number of cells available from a single donor

High Purity Viability: Guaranteed to have a purity of ≥90% as indicated by CD34+ expression

High viability: They are guaranteed to contain ≥2 million viable cells per ampoule

Certificate of Analysis is provided for each cell lot purchased. HIV, HBV, HCV not detected

Supporting media: Use X-VIVO® 20 Medium for the expansion and differentiation.

Choices in CD34+ cell types: (2C-101 H) and 2C-101 HX are available with HLA information. CD34+ cells derived from bone marrow (2M-101) and from adult mobilized blood (4Y-101D) are also available.


  • Humanized mice models creation 
  • CAR-T therapy process development 
  • Regenerative medicine 
  • Autoimmune disease 
  • Transplantations studies 
  • Immunology 
  • Cancer research


Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Need a Quote or Any Support?

Request a local representative to get back to you with additional information or pricing.

Immunotherapy and Hematopoietic Knowledge Center

The Immunotherapy and Hematopoietic Knowledge Center is dedicated to sharing interesting articles and resources related to immuno and hematopoietic research.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.